CD8A and neoplasm: In vitro, CD8+ Vδ1+ T cells which can recognize tumor-associate antigens in an MHC-dependent manner have been generated from human cord blood hematopoietic stem/progenitor cells (HSPC) using the OP9-DL system (15).